ResMed Inc. : Trading opportunity
ResMed could regain its upward trend after having run out of steam.
According to Surperformance ratings, the group has strong fundamentals,as shown by the business predictability. In addition, analysts have recently revised upward their earnings estimates and now expect a profit of USD 2.19 per share for the current year.
ResMed is in an uptrend in the medium and long term, but the last bearish movement returns close to a major support level (USD 42.8), level corresponding to the 20-week moving average. This threshold, if preserved, will enable to enjoy the bullish movement towards the USD 48.4 resistance.
It seems opportune to take a long position around the USD 42.8 support area with in line of sight the USD 48.4 resistance. A stop loss must be placed under the USD 42.8 support.
 |
|
Copyright (c) 2013 4-Traders.com |
Disclaimer : 4-Traders.com is not registered as a securities broker-dealer or investment adviser with any jurisdiction and is not providing any personalized financial, investment or tax advice. 4-Traders cannot assess or guarantee the suitability of any particular investment to any personal situation. Accordingly, you bear complete responsibility for your own investment, financial, and tax research and decisions and should seek the advice of a qualified professional prior to making any decisions based on 4-Traders' website information. This article is provided solely for informational purposes, and does not constitute an offer or solicitation to buy or sell any securities. All opinions expressed and information and data provided therein are subject to change without notice.
|
|
|
|
|
Valuation |
2013e |
2014e |
|
PER (Price / EPS)
|
22,7x |
21,7x |
|
Capitalization / Revenue
|
4,71x |
4,28x |
|
EV / Revenue
|
4,26x |
3,76x |
|
EV / EBITDA
|
14,2x |
13,1x |
|
Yield (DPS / Price)
|
1,41% |
1,60% |
| Profitability |
2013e |
2014e |
|
Operating Margin (EBIT / Sales)
|
24,9% |
24,6% |
|
operating laverage (Delta EBIT / Delta Sales)
|
2,02x |
0,87x |
|
Net Margin (Net Profit / Revenue)
|
21,3% |
20,9% |
|
ROA (Net Profit / Asset)
|
21,9% |
22,2% |
|
ROE (Net Profit / Equities)
|
19,3% |
18,6% |
|
Rate of Dividend
|
32,0% |
34,7% |
|
|
|
